Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motaz Qadan

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
Turkish Journal of Anaesthesiology and Reanimation|September 5, 2017
WHO Needs High FIO<sub>2</sub>?Ozan Akca, Lorenzo Ball, F Javier Belda, et al.
Surgery|August 5, 2022
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapyGuoliang Qiao, Crisanta H Ilagan, Carlos Fernandez-Del Castillo, et al.
Journal of the American College of Surgeons|February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat AnalysisZhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery|October 13, 2023
The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative ResectionSarah Finton, Louisa Bolm, Martina Nebbia, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreasClifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Annals of Surgery|December 19, 2019
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal AdenocarcinomaBiqi Zhang, Grace C Lee, Motaz Qadan, et al.
Annals of Surgery|October 21, 2020
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic AdenocarcinomaAkhil Chawla, Motaz Qadan, Carlos Fernandez-Del Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2026
Neoadjuvant stereotactic body radiation therapy plus immune therapy favorably remodels the hepatocellular carcinoma tumor microenvironmentZoe Cosner, Zhoubo Guo, Cole Nawrocki, et al.
JAMA Surgery|December 17, 2025
Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine TumorsMarco Ventin, Shahrzad Arya, Liti Zhang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 5, 2026
Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched AnalysisTakayuki Shimizu, Serena Zheng, Shimpei Maeda, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Turkish Journal of Anaesthesiology and Reanimation|September 5, 2017
WHO Needs High FIO<sub>2</sub>?Ozan Akca, Lorenzo Ball, F Javier Belda, et al.
Surgery|August 5, 2022
Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapyGuoliang Qiao, Crisanta H Ilagan, Carlos Fernandez-Del Castillo, et al.
Journal of the American College of Surgeons|February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat AnalysisZhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
Annals of Surgery|October 13, 2023
The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative ResectionSarah Finton, Louisa Bolm, Martina Nebbia, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreasClifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
Annals of Surgery|December 19, 2019
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal AdenocarcinomaBiqi Zhang, Grace C Lee, Motaz Qadan, et al.
Annals of Surgery|October 21, 2020
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic AdenocarcinomaAkhil Chawla, Motaz Qadan, Carlos Fernandez-Del Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2026
Neoadjuvant stereotactic body radiation therapy plus immune therapy favorably remodels the hepatocellular carcinoma tumor microenvironmentZoe Cosner, Zhoubo Guo, Cole Nawrocki, et al.
JAMA Surgery|December 17, 2025
Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine TumorsMarco Ventin, Shahrzad Arya, Liti Zhang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 5, 2026
Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched AnalysisTakayuki Shimizu, Serena Zheng, Shimpei Maeda, et al.
Pageof 23